Attacking heart failure in the young

Pediatric cardiology experts from around the world will gather at the Indiana University School of Medicine for the inaugural Riley Heart Center Symposium on Cardiac Development Sept. 8-9 at Riley Hospital for Children.

The symposium, organized by the Riley Heart Research Center, is targeted to basic scientists, clinical cardiologists and heart surgeons, and will focus on issues pertaining to the onset and treatment of heart failure in infants and children.

Congenital heart disease is the most common birth defect in infants and children and many of those structural abnormalities can lead to heart failure. Last year the National Institutes of Health's National Heart, Lung and Blood Institute awarded the IU School of Medicine $11.5 million, the only institutional grant looking at the cause and treatment of heart failure in children.

Among the areas to be explored at the symposium are:

  • How abnormal regulation of genes can lead to abnormal heart formation
  • Blocking the signals and pathways that cause heart muscle to die
  • Controls on the number and size of heart muscle cells during heart development
  • Repairing damaged heart tissue
  • Interventional strategies in newborn hearts

The Riley Heart Research Center, directed by Loren Field, Ph.D., is located in the Herman B Wells Center for Pediatric Research in the Department of Pediatrics at the IU School of Medicine. Riley Hospital is known for its outstanding pediatric cardiac clinical care and surgery.

For additional information on the symposium and the Riley Heart Research Center, go to http://www.heartresearch.iupui.edu.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New nasal spray form of bumetanide shows promise for heart failure treatment